Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Anesiva and Sigma-Tau have signed an agreement granting an exclusive license to Sigma-Tau for the marketing and distribution of Anesiva's Zingo powder intradermal injection system in six European countries; Italy, France, Germany, Netherlands, Belgium and Luxembourg.
Subscribe to our email newsletter
Under the terms of the agreement, Sigma-Tau will oversee all necessary regulatory filings, and will be responsible for all marketing and sales of Zingo in their territory. The agreement between Anesiva and Sigma-Tau includes an upfront payment to Anesiva and transfer price, as well as milestone payments.
John McLaughlin, CEO of Anesiva, said: “This licensing agreement covers the majority of Europe and we are currently in advanced discussions with other potential partners for certain additional countries.”